Spots Global Cancer Trial Database for serplulimab and neoadjuvant therapy
Every month we try and update this database with for serplulimab and neoadjuvant therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer | NCT05882513 | NSCLC Neoadjuvant The... | Serplulimab and... surgical resect... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
